Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
60,890,488
-
Share change
-
-5,036,818
-
Total reported value
-
$2,810,077,563
-
Put/Call ratio
-
125%
-
Price per share
-
$46.15
-
Number of holders
-
157
-
Value change
-
-$244,072,957
-
Number of buys
-
56
-
Number of sells
-
103
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q3 2021
As of 30 Sep 2021,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,890,488 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Bellevue Group AG, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, STATE STREET CORP, and Casdin Capital, LLC.
This page lists
157
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.